Form 8-K - Current report:
SEC Accession No. 0001070081-24-000006
Filing Date
2024-01-25
Accepted
2024-01-25 16:06:28
Documents
13
Period of Report
2024-01-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20240125x8k.htm   iXBRL 8-K 43681
2 EX-99.1 tmb-20240125xex99d1.htm EX-99.1 16945
  Complete submission text file 0001070081-24-000006.txt   182641

Data Files

Seq Description Document Type Size
3 EX-101.SCH tmb-20240125.xsd EX-101.SCH 3124
4 EX-101.LAB tmb-20240125_lab.xml EX-101.LAB 15266
5 EX-101.PRE tmb-20240125_pre.xml EX-101.PRE 9657
7 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240125x8k_htm.xml XML 4675
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 24562201
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)